Latest Articles

Publication Date
Seneca Healthcare District Adds Minimally Invasive Endometrial Ablation - SierraDailyNews.com

Seneca Healthcare District Adds Minimally Invasive Endometrial Ablation SierraDailyNews.com

Published: Sept. 11, 2026, 4:31 p.m.
The effect of intravenous remdesivir on endometrial receptivity in female mice.

Pregnant women with coronavirus disease 2019 (COVID-19) are more likely than nonpregnant women to require admission to an intensive care unit, and many may require antiviral therapy. Remdesivir, an antiviral …

Published: Sept. 9, 2026, midnight
Deciphering the Role of ZEB1 as a Central Regulator of Epithelial-Mesenchymal Transition and Hormonal Resistance in Endometriosis.

Endometriosis is a chronic inflammatory and sex steroid hormone-dependent gynaecologic disease, characterised by endometrial cell proliferation outside the uterine cavity, often accompanied by fibrosis, progesterone resistance, and high recurrence despite …

Published: Sept. 9, 2026, midnight
Lipid-lowering agents linked to improved survival in women with endometrial Ca - Contemporary OB/GYN

Lipid-lowering agents linked to improved survival in women with endometrial Ca Contemporary OB/GYN

Published: Sept. 8, 2026, 8 p.m.
Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities - Today@Wayne

Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities Today@Wayne

Published: Sept. 8, 2026, 3:25 p.m.
Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities - today.wayne.edu

Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities today.wayne.edu

Published: Sept. 8, 2026, 3:25 p.m.
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Business Wire

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 Business Wire

Published: Sept. 8, 2026, 11:30 a.m.
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - businesswire.com

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 businesswire.com

Published: Sept. 8, 2026, 11:30 a.m.
The hidden impacts of endocrine-disrupting chemicals on endometrial and pregnancy health.

Endocrine-disrupting chemicals (EDCs) are ubiquitous environmental contaminants that interfere with hormone signalling and are increasingly linked to adverse reproductive outcomes. This viewpoint highlights emerging evidence that EDC exposure disrupts both …

Published: Sept. 8, 2026, midnight
Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis.

Endometriosis (EMs) is a common gynecological disorder in women of reproductive age, often presenting with pelvic pain and infertility. Its progression is closely linked to estrogen levels. While hormonal therapies …

Published: Sept. 8, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!